dr Karolina Dzwonek

Affiliation:

Celon Pharma Sp. z o.o.

Publications:

1. Design and development of CPL-407-22 – novel, potent and selective JAK2 protein kinase inhibitor.
2. Novel small molecule STAT3 inhibitors in cancer therapy.